193 related articles for article (PubMed ID: 36592158)
1. MYB sustains hypoxic survival of pancreatic cancer cells by facilitating metabolic reprogramming.
Anand S; Khan MA; Zubair H; Sudan SK; Vikramdeo KS; Deshmukh SK; Azim S; Srivastava SK; Singh S; Singh AP
EMBO Rep; 2023 Mar; 24(3):e55643. PubMed ID: 36592158
[TBL] [Abstract][Full Text] [Related]
2. Expression of MUC17 is regulated by HIF1α-mediated hypoxic responses and requires a methylation-free hypoxia responsible element in pancreatic cancer.
Kitamoto S; Yokoyama S; Higashi M; Yamada N; Matsubara S; Takao S; Batra SK; Yonezawa S
PLoS One; 2012; 7(9):e44108. PubMed ID: 22970168
[TBL] [Abstract][Full Text] [Related]
3. BICD1 mediates HIF1α nuclear translocation in mesenchymal stem cells during hypoxia adaptation.
Lee HJ; Jung YH; Oh JY; Choi GE; Chae CW; Kim JS; Lim JR; Kim SY; Lee SJ; Seong JK; Han HJ
Cell Death Differ; 2019 Sep; 26(9):1716-1734. PubMed ID: 30464225
[TBL] [Abstract][Full Text] [Related]
4. MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer.
Chaika NV; Gebregiworgis T; Lewallen ME; Purohit V; Radhakrishnan P; Liu X; Zhang B; Mehla K; Brown RB; Caffrey T; Yu F; Johnson KR; Powers R; Hollingsworth MA; Singh PK
Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13787-92. PubMed ID: 22869720
[TBL] [Abstract][Full Text] [Related]
5. RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer.
Kang R; Hou W; Zhang Q; Chen R; Lee YJ; Bartlett DL; Lotze MT; Tang D; Zeh HJ
Cell Death Dis; 2014 Oct; 5(10):e1480. PubMed ID: 25341034
[TBL] [Abstract][Full Text] [Related]
6. P4HA1/HIF1α feedback loop drives the glycolytic and malignant phenotypes of pancreatic cancer.
Cao XP; Cao Y; Li WJ; Zhang HH; Zhu ZM
Biochem Biophys Res Commun; 2019 Aug; 516(3):606-612. PubMed ID: 31239153
[TBL] [Abstract][Full Text] [Related]
7. STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells.
Pawlus MR; Wang L; Hu CJ
Oncogene; 2014 Mar; 33(13):1670-9. PubMed ID: 23604114
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer.
Li Y; Zhang D; Wang X; Yao X; Ye C; Zhang S; Wang H; Chang C; Xia H; Wang YC; Fang J; Yan J; Ying H
Sci Rep; 2015 Jul; 5():12495. PubMed ID: 26205124
[TBL] [Abstract][Full Text] [Related]
9. MiR-548an, Transcriptionally Downregulated by HIF1α/HDAC1, Suppresses Tumorigenesis of Pancreatic Cancer by Targeting Vimentin Expression.
Zhu S; He C; Deng S; Li X; Cui S; Zeng Z; Liu M; Zhao S; Chen J; Jin Y; Chen H; Deng S; Liu Y; Wang C; Zhao G
Mol Cancer Ther; 2016 Sep; 15(9):2209-19. PubMed ID: 27353169
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4.
Mittal K; Kaur J; Sharma S; Sharma N; Wei G; Choudhary I; Imhansi-Jacob P; Maganti N; Pawar S; Rida P; Toss MS; Aleskandarany M; Janssen EA; Søiland H; Gupta MV; Reid MD; Rakha EA; Aneja R
Mol Cancer Res; 2022 Apr; 20(4):596-606. PubMed ID: 34933912
[TBL] [Abstract][Full Text] [Related]
11. HIF1α-dependent upregulation of ATAD2 promotes proliferation and migration of stomach cancer cells in response to hypoxia.
Nayak A; Roy AD; Rout N; Singh SP; Bhattacharyya A; Roychowdhury A
Biochem Biophys Res Commun; 2020 Mar; 523(4):916-923. PubMed ID: 31959473
[TBL] [Abstract][Full Text] [Related]
12. Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.
Logsdon DP; Grimard M; Luo M; Shahda S; Jiang Y; Tong Y; Yu Z; Zyromski N; Schipani E; Carta F; Supuran CT; Korc M; Ivan M; Kelley MR; Fishel ML
Mol Cancer Ther; 2016 Nov; 15(11):2722-2732. PubMed ID: 27535970
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic ER stress suppresses β-catenin expression and promotes cooperation between the transcription factors XBP1 and HIF1α for cell survival.
Xia Z; Wu S; Wei X; Liao Y; Yi P; Liu Y; Liu J; Liu J
J Biol Chem; 2019 Sep; 294(37):13811-13821. PubMed ID: 31350332
[TBL] [Abstract][Full Text] [Related]
14. HIF1α-Regulated Expression of the Fatty Acid Binding Protein Family Is Important for Hypoxic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
Singh RK; Bose D; Robertson ES
J Virol; 2021 May; 95(12):. PubMed ID: 33789996
[TBL] [Abstract][Full Text] [Related]
15. Steroid receptor coactivator-3 regulates glucose metabolism in bladder cancer cells through coactivation of hypoxia inducible factor 1α.
Zhao W; Chang C; Cui Y; Zhao X; Yang J; Shen L; Zhou J; Hou Z; Zhang Z; Ye C; Hasenmayer D; Perkins R; Huang X; Yao X; Yu L; Huang R; Zhang D; Guo H; Yan J
J Biol Chem; 2014 Apr; 289(16):11219-11229. PubMed ID: 24584933
[TBL] [Abstract][Full Text] [Related]
16. MDM2 regulates hypoxic hypoxia-inducible factor 1α stability in an E3 ligase, proteasome, and PTEN-phosphatidylinositol 3-kinase-AKT-dependent manner.
Joshi S; Singh AR; Durden DL
J Biol Chem; 2014 Aug; 289(33):22785-22797. PubMed ID: 24982421
[TBL] [Abstract][Full Text] [Related]
17. HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis.
Amarilio R; Viukov SV; Sharir A; Eshkar-Oren I; Johnson RS; Zelzer E
Development; 2007 Nov; 134(21):3917-28. PubMed ID: 17913788
[TBL] [Abstract][Full Text] [Related]
18. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
[TBL] [Abstract][Full Text] [Related]
19. Metabolic reprogramming of Kaposi's sarcoma associated herpes virus infected B-cells in hypoxia.
Singh RK; Lang F; Pei Y; Jha HC; Robertson ES
PLoS Pathog; 2018 May; 14(5):e1007062. PubMed ID: 29746587
[TBL] [Abstract][Full Text] [Related]
20. LncRNA-MTA2TR functions as a promoter in pancreatic cancer via driving deacetylation-dependent accumulation of HIF-1α.
Zeng Z; Xu FY; Zheng H; Cheng P; Chen QY; Ye Z; Zhong JX; Deng SJ; Liu ML; Huang K; Li Q; Li W; Hu YH; Wang F; Wang CY; Zhao G
Theranostics; 2019; 9(18):5298-5314. PubMed ID: 31410216
[No Abstract] [Full Text] [Related]
[Next] [New Search]
